Celiprolol HCl (BioDeep_00000668443)
代谢物信息卡片
Celiprolol hydrochloride
化学式: C20H34ClN3O4 (415.2237714000001)
中文名称: 盐酸塞利洛尔
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CCN(CC)C(=O)NC1=CC(=C(C=C1)OCC(CNC(C)(C)C)O)C(=O)C.Cl
InChI: 1H
描述信息
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents
D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
同义名列表
2 个代谢物同义名
数据库引用编号
6 个数据库交叉引用编号
- ChEBI: CHEBI:31385
- KEGGdrug: D01741
- PubChem: 42373
- ChEMBL: CHEMBL1742424
- MeSH: Celiprolol
- CAS: 57470-78-7
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Päivi Hirvensalo, Aleksi Tornio, Tuija Tapaninen, Maria Paile-Hyvärinen, Mikko Neuvonen, Janne T Backman, Mikko Niemi. Pharmacogenomics of celiprolol - evidence for a role of P-glycoprotein and organic anion transporting polypeptide 1A2 in celiprolol pharmacokinetics.
Clinical and translational science.
2022 02; 15(2):409-421. doi:
10.1111/cts.13159. [PMID: 34585840] - Junichiro Sonoda, Kenji Ogata, Naoki Yoshikawa, Keizo Sato, Ryuji Ikeda, Yoshihiro Shimodozono. Impact of green tea intake on the pharmacokinetics of celiprolol in healthy subjects.
International journal of clinical pharmacology and therapeutics.
2021 Mar; 59(3):198-201. doi:
10.5414/cp203795. [PMID: 33210993] - Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Molecular pharmacology.
2019 11; 96(5):629-640. doi:
10.1124/mol.119.115964. [PMID: 31515284] - Kazuo Eguchi, Satoshi Hoshide, Kazuomi Kario. Effects of Celiprolol and Bisoprolol on Blood Pressure, Vascular Stiffness, and Baroreflex Sensitivity.
American journal of hypertension.
2015 Jul; 28(7):858-67. doi:
10.1093/ajh/hpu245. [PMID: 25577782] - Dariusz Andrzejczak, Dorota Górska. The effects of celiprolol on serum concentrations of proinflammatory cytokines in hypertensive (SHR) and normotensive (WKY) rats.
Pharmacological reports : PR.
2014 Feb; 66(1):68-73. doi:
10.1016/j.pharep.2013.08.006. [PMID: 24905309] - Nozomu Miyazaki, Shingen Misaka, Hiroshi Ogata, Tetsuhito Fukushima, Junko Kimura. Effects of itraconazole, dexamethasone and naringin on the pharmacokinetics of nadolol in rats.
Drug metabolism and pharmacokinetics.
2013; 28(4):356-61. doi:
10.2133/dmpk.dmpk-12-rg-111. [PMID: 23419354] - Shimako Tanaka, Shinya Uchida, Sachiko Miyakawa, Naoki Inui, Kazuhiko Takeuchi, Hiroshi Watanabe, Noriyuki Namiki. Comparison of inhibitory duration of grapefruit juice on organic anion-transporting polypeptide and cytochrome P450 3A4.
Biological & pharmaceutical bulletin.
2013; 36(12):1936-41. doi:
10.1248/bpb.b13-00538. [PMID: 24292052] - E Mizuta, S B Utami, A Ohtahara, S Endo, M Mishima, A Hasegawa, K Yamada, M Kato, K Yamamoto, K Ogino, H Ninomiya, S Miyazaki, T Hamada, S-i Taniguchi, J Cheng, I Hisatome. A vasodilating β1 blocker celiprolol inhibits muscular release of uric acid precursor in patients with essential hypertension.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
2013 Jan; 45(1):69-73. doi:
10.1055/s-0032-1321872. [PMID: 22893261] - Akiko Itohda, Kimiko Tsutsumi, Hiromitsu Imai, Miyuki Iwao, Tsutomu Kotegawa, Kyoichi Ohashi. Determination of celiprolol in human plasma using high performance liquid chromatography with fluorescence detection for clinical application.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2012 Sep; 904(?):88-92. doi:
10.1016/j.jchromb.2012.07.026. [PMID: 22889991] - F Belal, M Sharaf El-Din, F Aly, M Hefnawy, M El-Awady. Fluorometric determination of bopindolol and celiprolol in pharmaceutical preparations and biological fluids.
Journal of fluorescence.
2012 Jul; 22(4):1141-50. doi:
10.1007/s10895-012-1053-1. [PMID: 22477063] - Yoshiyuki Minamide, Yukio Osawa, Hiroshi Nishida, Harue Igarashi, Shinobu Kudoh. A highly sensitive LC-MS/MS method capable of simultaneously quantitating celiprolol and atenolol in human plasma for a cassette cold-microdosing study.
Journal of separation science.
2011 Jul; 34(13):1590-8. doi:
10.1002/jssc.201100089. [PMID: 21595025] - Lihui Zheng, Lan Zhang, Ping Tong, Xinyu Zheng, Yuwu Chi, Guonan Chen. Highly sensitive transient isotachophoresis sample stacking coupling with capillary electrophoresis-amperometric detection for analysis of doping substances.
Talanta.
2010 Jun; 81(4-5):1288-94. doi:
10.1016/j.talanta.2010.02.023. [PMID: 20441897] - Yukio Kato, Tatsuya Miyazaki, Takashi Kano, Tomoko Sugiura, Yoshiyuki Kubo, Akira Tsuji. Involvement of influx and efflux transport systems in gastrointestinal absorption of celiprolol.
Journal of pharmaceutical sciences.
2009 Jul; 98(7):2529-39. doi:
10.1002/jps.21618. [PMID: 19067419] - Peter Mikus, Katarína Maráková, Jozef Marák, Alexandra Planková, Iva Valásková, Emil Havránek. Direct determination of celiprolol in human urine using on-line coupled ITP-CZE method with fiber-based DAD.
Electrophoresis.
2008 Nov; 29(22):4561-7. doi:
10.1002/elps.200800079. [PMID: 18975302] - Yoshihiro Uesawa, Kiminori Mohri. Hesperidin in orange juice reduces the absorption of celiprolol in rats.
Biopharmaceutics & drug disposition.
2008 Apr; 29(3):185-8. doi:
10.1002/bdd.603. [PMID: 18344215] - Toshio Hayashi, Packiasamy A R Juliet, Asaka Miyazaki-Akita, Jun Funami, Hisako Matsui-Hirai, Akiko Fukatsu, Akihisa Iguchi. beta1 antagonist and beta2 agonist, celiprolol, restores the impaired endothelial dependent and independent responses and decreased TNFalpha in rat with type II diabetes.
Life sciences.
2007 Jan; 80(6):592-9. doi:
10.1016/j.lfs.2006.10.018. [PMID: 17141277] - Wenxia Zhang, Theresa May Chin Tan, Lee-Yong Lim. Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats.
Drug metabolism and disposition: the biological fate of chemicals.
2007 Jan; 35(1):110-5. doi:
10.1124/dmd.106.011072. [PMID: 17050652] - Jyrki T Olkinuora, Jorma Viikari, Hannu Vanhanen, Niina Makkonen, Tero Kalliomäki. Effects of celiprolol and simvastatin on the calculated risk of coronary heart disease (the Celisimva study).
Scandinavian cardiovascular journal : SCJ.
2006 Jun; 40(3):160-6. doi:
10.1080/14017430600801675. [PMID: 16798663] - Gregory P Vyssoulis, Andreas G Marinakis, Konstantinos A Aznaouridis, Eva A Karpanou, Athina N Arapogianni, Dennis V Cokkinos, Christodoulos I Stefanadis. The impact of third-generation beta-blocker antihypertensive treatment on endothelial function and the prothrombotic state: effects of smoking.
American journal of hypertension.
2004 Jul; 17(7):582-9. doi:
10.1016/j.amjhyper.2004.03.668. [PMID: 15233977] - E Caudron, S Laurent, E M Billaud, P Prognon. Simultaneous determination of the acid/base antihypertensive drugs celiprolol, bisoprolol and irbesartan in human plasma by liquid chromatography.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2004 Mar; 801(2):339-45. doi:
10.1016/j.jchromb.2003.11.009. [PMID: 14751804] - Jari J Lilja, Laura Juntti-Patinen, Pertti J Neuvonen. Orange juice substantially reduces the bioavailability of the beta-adrenergic-blocking agent celiprolol.
Clinical pharmacology and therapeutics.
2004 Mar; 75(3):184-90. doi:
10.1016/j.clpt.2003.11.002. [PMID: 15001969] - J J Lilja, M Niemi, P J Neuvonen. Rifampicin reduces plasma concentrations of celiprolol.
European journal of clinical pharmacology.
2004 Jan; 59(11):819-24. doi:
10.1007/s00228-003-0694-z. [PMID: 14614579] - Jari J Lilja, Janne T Backman, Jouko Laitila, Harri Luurila, Pertti J Neuvonen. Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol.
Clinical pharmacology and therapeutics.
2003 Mar; 73(3):192-8. doi:
10.1067/mcp.2003.26. [PMID: 12621384] - K Heusser, H P Schobel, A Adamidis, T Fischer, H Frank. Cardiovascular effects of beta-blockers with and without intrinsic sympathomimetic activity. A comparison between celiprolol and metoprolol.
Kidney & blood pressure research.
2002; 25(1):34-41. doi:
10.1159/000049433. [PMID: 11834875] - H S Savale, K K Pandya, T P Gandhi, I A Modi, R I Modi, M C Satia. Plasma analysis of celiprolol by HPTLC: a useful technique for pharmacokinetic studies.
Journal of AOAC International.
2001 Jul; 84(4):1252-7. doi:
10.1093/jaoac/84.4.1252. [PMID: 11501929] - M Totsuka, Y Miyashita, Y Ito, T Oyama, S Hashiguti, H Watanabe, K Shirai, T Ban, H Ishihara, K Yamamoto, E Kawano, J Mori, M Kanechi. [The effect of celiprolol hydrochloride for lipid metabolism--especially for the low density lipoprotein particle size].
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.
2001 May; 38(3):352-9. doi:
10.3143/geriatrics.38.352. [PMID: 11431890] - M Kakoki, Y Hirata, H Hayakawa, E Suzuki, D Nagata, H Nishimatsu, K Kimura, A Goto, M Omata. Effects of vasodilatory antihypertensive agents on endothelial dysfunction in rats with ischemic acute renal failure.
Hypertension research : official journal of the Japanese Society of Hypertension.
2000 Sep; 23(5):527-33. doi:
10.1291/hypres.23.527. [PMID: 11016809] - E Savontaus, J Rouru, K Malminiemi, V Luukkaa, U Pesonen, M Koulu, R Huupponen. Effects of chronic celiprolol treatment on brown fat, feeding, and drinking in fa/fa Zucker rats.
Pharmacology, biochemistry, and behavior.
2000 Apr; 65(4):719-24. doi:
10.1016/s0091-3057(99)00254-3. [PMID: 10764928] - M Pietilä, K Malminiemi, R Huupponen, J Rouru, K Pulkki, E Pere, L M Voipio-Pulkki. Celiprolol augments the effect of physical exercise on insulin sensitivity and serum lipid levels in chronic heart failure.
European journal of heart failure.
2000 Mar; 2(1):81-90. doi:
10.1016/s1388-9842(00)00054-4. [PMID: 10742707] - K Malminiemi. Long-term celiprolol therapy lowers fasting plasma leptin levels. Celiprolol Multicenter Study Group.
Cardiovascular drugs and therapy.
2000 Feb; 14(1):67-75. doi:
10.1023/a:1007847306219. [PMID: 10755203] - Y Daali, S Cherkaoui, P Christen, J L Veuthey. Experimental design for enantioselective separation of celiprolol by capillary electrophoresis using sulfated beta-cyclodextrin.
Electrophoresis.
1999 Nov; 20(17):3424-31. doi:
10.1002/(sici)1522-2683(19991101)20:17<3424::aid-elps3424>3.0.co;2-z. [PMID: 10608710] - R Fogari, A Zoppi, L Corradi, P Preti, A Mugellini, P Lusardi. Beta-blocker effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia.
Journal of cardiovascular pharmacology.
1999 Apr; 33(4):534-9. doi:
10.1097/00005344-199904000-00004. [PMID: 10218722] - S Jacob, D L Fogt, G J Dietze, E J Henriksen. The beta2-adrenergic modulator celiprolol reduces insulin resistance in obese Zucker rats.
Life sciences.
1999; 64(22):2071-9. doi:
10.1016/s0024-3205(99)00154-x. [PMID: 10374932] - M Kakoki, Y Hirata, H Hayakawa, H Nishimatsu, Y Suzuki, D Nagata, E Suzuki, K Kikuchi, T Nagano, M Omata. Effects of vasodilatory beta-adrenoceptor antagonists on endothelium-derived nitric oxide release in rat kidney.
Hypertension (Dallas, Tex. : 1979).
1999 Jan; 33(1 Pt 2):467-71. doi:
10.1161/01.hyp.33.1.467. [PMID: 9931149] - A J Braza, P Modamio, E L Mariño. Determination of celiprolol and oxprenolol in human plasma by high-performance liquid chromatography and the analytical error function.
Journal of chromatography. B, Biomedical sciences and applications.
1998 Nov; 718(2):267-72. doi:
10.1016/s0378-4347(98)00378-8. [PMID: 9840437] - C L Papadopoulos, B Kokkas, P Kotridis, M Karamouzis, M Haldoupi, A Platis, G Dadoush, I Kanonidis. Effect of the beta 1-blocker/beta 2-agonist celiprolol on atrial natriuretic peptide plasma levels in hypertensive patients.
Cardiovascular drugs and therapy.
1998 Sep; 12(4):345-6. doi:
10.1023/a:1007712631955. [PMID: 9825178] - A Oksa, V Fedelesová, V Spustová, R Dzúrik. [Celiprolol improves glucose metabolism in essential hypertension].
Vnitrni lekarstvi.
1998 Feb; 44(2):63-7. doi:
NULL. [PMID: 9820078] - K Malminiemi, J Lahtela, O Malminiemi, K Ala-Kaila, R Huupponen. Insulin sensitivity in a long-term crossover trial with celiprolol and other antihypertensive agents.
Journal of cardiovascular pharmacology.
1998 Jan; 31(1):140-5. doi:
10.1097/00005344-199801000-00019. [PMID: 9456288] - R J Milne, S Vander Hoorn, R T Jackson. A predictive model of the health benefits and cost effectiveness of celiprolol and atenolol in primary prevention of cardiovascular disease in hypertensive patients.
PharmacoEconomics.
1997 Sep; 12(3):384-408. doi:
10.2165/00019053-199712030-00010. [PMID: 10170463] - C M Erley, E D Berger, N Heyne, M Klass, D Krämer, N Braun, S Wolf, T Risler. [Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors].
Deutsche medizinische Wochenschrift (1946).
1997 Aug; 122(31-32):953-8. doi:
10.1055/s-2008-1047714. [PMID: 9280714] - A Head, S Maxwell, M J Kendall. Exercise metabolism in healthy volunteers taking celiprolol, atenolol, and placebo.
British journal of sports medicine.
1997 Jun; 31(2):120-5. doi:
10.1136/bjsm.31.2.120. [PMID: 9192124] - A Witek, L Przyborowski. Thin-layer chromatographic analysis of some beta-blocking drugs in plasma.
Acta poloniae pharmaceutica.
1997 May; 54(3):183-6. doi:
NULL. [PMID: 9511444] - W Van Mieghem. Evaluation of glucose tolerance during treatment with celiprolol in patients with mild arterial hypertension without diabetes mellitus. The Genker General Practitioners.
Acta clinica Belgica.
1997; 52(6):360-6. doi:
10.1080/17843286.1997.11718601. [PMID: 9489131] - K Malminiemi, H Laine, M J Knuuti, U Ruotsalainen, V Oikonen, M Haaparanta, P Nuutila. Acute effects of celiprolol on muscle blood flow and insulin sensitivity: studies using [15O]-water, [18F]-fluorodeoxyglucose and positron emission tomography.
European journal of clinical pharmacology.
1997; 52(1):19-26. doi:
10.1007/s002280050243. [PMID: 9143862] - F C Chiu, K Raymond. Validated assay for the determination of celiprolol in plasma using high-performance liquid chromatography and a silanol deactivated reversed-phase support.
Journal of chromatography. B, Biomedical applications.
1996 Dec; 687(2):462-5. doi:
10.1016/s0378-4347(96)00246-0. [PMID: 9017473] - C M Erley, M Klass, D Krämer, E Berger, N Heyne, N Braun, S Wolf, T Risler. Randomized controlled trial of ACE-inhibitors and beta-blockers with and without vasodilating activity in chronic glomerulonephritis.
International journal of clinical pharmacology and therapeutics.
1996 Nov; 34(11):504-9. doi:
NULL. [PMID: 8937934] - R Verbesselt, A Zugravu, T B Tjandramaga, P J De Schepper. Liquid chromatographic determination of total celiprolol or (S)-celiprolol and (R)-celiprolol simultaneously in human plasma.
Journal of chromatography. B, Biomedical applications.
1996 Aug; 683(2):231-6. doi:
10.1016/0378-4347(96)00110-7. [PMID: 8891920] - J E Sanderson, W W Chan, Y T Hung, S K Chan, I O Shum, K Raymond, K S Woo. Effect of low dose beta blockers on atrial and ventricular (B type) natriuretic factor in heart failure: a double blind, randomised comparison of metoprolol and a third generation vasodilating beta blocker.
British heart journal.
1995 Nov; 74(5):502-7. doi:
10.1136/hrt.74.5.502. [PMID: 8562234] - C J Dunn, C M Spencer. Celiprolol. An evaluation of its pharmacological properties and clinical efficacy in the management of hypertension and angina pectoris.
Drugs & aging.
1995 Nov; 7(5):394-411. doi:
10.2165/00002512-199507050-00006. [PMID: 8573993] - E Lipka, I D Lee, P Langguth, H Spahn-Langguth, E Mutschler, G L Amidon. Celiprolol double-peak occurrence and gastric motility: nonlinear mixed effects modeling of bioavailability data obtained in dogs.
Journal of pharmacokinetics and biopharmaceutics.
1995 Jun; 23(3):267-86. doi:
10.1007/bf02354285. [PMID: 8834196] - T Haneda, K Okamoto, T Hiroshima, Y Kashiwagi, S Miyata, S Ohi, Y Nakamura, J Osaki, T Hirayama, Y Ogawa. The role of renal dopamine in the reduction of high blood pressure by beta 1-selective beta-blocker with intrinsic sympathomimetic activity in spontaneously hypertensive rats.
Hypertension research : official journal of the Japanese Society of Hypertension.
1995 Jun; 18 Suppl 1(?):S215-9. doi:
10.1291/hypres.18.supplementi_s215. [PMID: 8529067] - K Malminiemi. Association between serum lipids, glucose tolerance, and insulin sensitivity during 12 months of celiprolol treatment.
Cardiovascular drugs and therapy.
1995 Apr; 9(2):295-304. doi:
10.1007/bf00878674. [PMID: 7662596] - K Malminiemi, J T Lahtela, R Huupponen. Effects of celiprolol on insulin sensitivity and glucose tolerance in dyslipidemic hypertension.
International journal of clinical pharmacology and therapeutics.
1995 Mar; 33(3):156-63. doi:
NULL. [PMID: 7599914] - G D Johnston, G Vyssoulis, J Feely, R D Holden, D R Radley. Effect of celiprolol and metoprolol on lipids, fibrinogen and airways function in hyperlipidaemic hypertensives: a randomised double-blind long-term parallel group trial.
Journal of human hypertension.
1995 Feb; 9(2):123-9. doi:
NULL. [PMID: 7752174] - R W Hauck, C Schulz, H P Emslander, M Böhm. Pharmacological actions of the selective and non-selective beta-adrenoceptor antagonists celiprolol, bisoprolol and propranolol on human bronchi.
British journal of pharmacology.
1994 Nov; 113(3):1043-9. doi:
10.1111/j.1476-5381.1994.tb17098.x. [PMID: 7858847] - L M Böhlen, M de Courten, F Hafezi, S Shaw, W Riesen, P Weidmann. Insulin sensitivity and atrial natriuretic factor during beta-receptor modulation with celiprolol in normal subjects.
Journal of cardiovascular pharmacology.
1994 Jun; 23(6):877-83. doi:
10.1097/00005344-199406000-00004. [PMID: 7523778] - P Lijnen, R Van Hoof, A Amery. Effects of celiprolol vs. nifedipine on serum lipoproteins in patients with mild to moderate hypertension.
Cardiovascular drugs and therapy.
1994 Jun; 8(3):509-13. doi:
10.1007/bf00877929. [PMID: 7947368] - D R Rutledge, A H Abadi, L M Lopez. Simultaneous determination of verapamil and celiprolol in human plasma.
Journal of chromatographic science.
1994 Apr; 32(4):153-6. doi:
10.1093/chromsci/32.4.153. [PMID: 8200922] - M J Kendall, I Rajman. A risk-benefit assessment of celiprolol in the treatment of cardiovascular disease.
Drug safety.
1994 Mar; 10(3):220-32. doi:
10.2165/00002018-199410030-00004. [PMID: 7913813] - D R Rutledge, A H Abadi, L M Lopez. Liquid chromatographic determination of celiprolol, diltiazem, desmethyldiltiazem and deacetyldiltiazem in plasma using a short alkyl chain silanol deactivated column.
Journal of pharmaceutical and biomedical analysis.
1994 Jan; 12(1):135-40. doi:
10.1016/0731-7085(94)80022-7. [PMID: 8161601] - C A Dujovne, J Eff, L Ferraro, R J Goldstein, A M Gotto, W D Hall, W S Harris, S J Held, A Herd, D B Hunninghake. Comparative effects of atenolol versus celiprolol on serum lipids and blood pressure in hyperlipidemic and hypertensive subjects.
The American journal of cardiology.
1993 Nov; 72(15):1131-6. doi:
10.1016/0002-9149(93)90981-h. [PMID: 8237801] - L H Tung, G Jackman, B Campbell, S Louis, D Iakovidis, W J Louis. Partial agonist activity of celiprolol.
Journal of cardiovascular pharmacology.
1993 Mar; 21(3):484-8. doi:
10.1097/00005344-199303000-00020. [PMID: 7681512] - J Böhler, A Becker, P Reetze-Bonorden, R Woitas, E Keller, P Schollmeyer. Effect of antihypertensive drugs on glomerular hyperfiltration and renal haemodynamics. Comparison of captopril with nifedipine, metoprolol and celiprolol.
European journal of clinical pharmacology.
1993; 44 Suppl 1(?):S57-61. doi:
10.1007/bf01428396. [PMID: 8486148] - B Kofahl, D Henke, A Hettenbach, E Mutschler. Studies on placental transfer of celiprolol.
European journal of clinical pharmacology.
1993; 44(4):381-2. doi:
10.1007/bf00316477. [PMID: 8513850] - A Okrucká, J Pechán, I Balazovjech. The effect of short-term celiprolol therapy on platelet function in essential hypertension.
Cardiology.
1993; 82(6):399-404. doi:
10.1159/000175893. [PMID: 8402762] - G Rostock, R Günzel, D Glöckl. Solid-phase extraction and direct high-performance liquid chromatographic determination of celiprolol in plasma.
International journal of clinical pharmacology, therapy, and toxicology.
1992 Nov; 30(11):512-3. doi:
NULL. [PMID: 1490814] - R van Hoof, J P Desager, C Harvengt, R Fagard, P Lijnen, P Peerenboom, J Staessen, L Thijs, W Van Mieghem, A Amery. Comparison of the effect of celiprolol and nifedipine on blood pressure and plasma lipids.
Journal of cardiovascular pharmacology.
1992 Aug; 20(2):268-73. doi:
10.1097/00005344-199208000-00012. [PMID: 1381018] - P Lijnen. Biochemical mechanisms involved in the beta-blocker-induced changes in serum lipoproteins.
American heart journal.
1992 Aug; 124(2):549-56. doi:
10.1016/0002-8703(92)90634-8. [PMID: 1353298] - R A Robson, P G Bridgman, J E Wells, R R Bailey, K L Lynn. The effect of celiprolol on glomerular filtration rate and renal blood flow in patients with chronic renal impairment and healthy volunteers.
British journal of clinical pharmacology.
1992 Apr; 33(4):454-7. doi:
10.1111/j.1365-2125.1992.tb04068.x. [PMID: 1349496] - R J Milne, M M Buckley. Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease.
Drugs.
1991 Jun; 41(6):941-69. doi:
10.2165/00003495-199141060-00009. [PMID: 1715268] - D B Hunninghake. The effects of cardioselective vasodilating beta-blockers on lipids.
American heart journal.
1991 Mar; 121(3 Pt 2):1029-32. doi:
10.1016/0002-8703(91)90616-p. [PMID: 1671728] - D B Hunninghake. Effects of celiprolol and other antihypertensive agents on serum lipids and lipoproteins.
American heart journal.
1991 Feb; 121(2 Pt 2):696-701. doi:
10.1016/0002-8703(91)90449-r. [PMID: 1671189] - W H Frishman. Clinical perspective on celiprolol: cardioprotective potential.
American heart journal.
1991 Feb; 121(2 Pt 2):724-9. doi:
10.1016/0002-8703(91)90453-o. [PMID: 1671192] - R Fogari, A Zoppi, F Tettamanti, G Malamani, C Pasotti. The effect of celiprolol on the blood lipid profile in hypertensive patients with high cholesterol levels.
Cardiovascular drugs and therapy.
1991 Jan; 4 Suppl 6(?):1287-90. doi:
10.1007/bf00114235. [PMID: 1826213] - S Ochi, Y Kimura, T Matsuzaki, S Hayashi, A Motonaga, M Tanaka, H Fukui, A Yamazaki, K Matsumura, A Miura. [Pharmacological studies of celiprolol: III. Effects of celiprolol on the cardiovascular system and renal function, and its antiarrhythmic effects].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica.
1990 Apr; 95(4):209-27. doi:
10.1254/fpj.95.4_209. [PMID: 1973400] - K Strein, G Sponer. Experimental and clinical pharmacology of carvedilol and other drugs combining vasodilation and beta-adrenoceptor antagonism in a single molecule.
Zeitschrift fur Kardiologie.
1990; 79 Suppl 3(?):89-98. doi:
. [PMID: 1983054] - S Balasubramaniam, L A Simons, J B Hickie, S Chang. The effects of adrenergic blockade on lipoproteins using the rat as an experimental model.
Artery.
1990; 17(2):60-70. doi:
NULL. [PMID: 1968740] - C Nanoff, M Ströher, H Haschkowitz, W Schütz, H Pittner. Desensitization pattern of cardiac beta-adrenoceptor subtypes by prolonged in vivo infusion of pindolol and celiprolol in rats.
Basic research in cardiology.
1990 Jan; 85(1):88-95. doi:
10.1007/bf01907017. [PMID: 1970235] - C Hartmann, M Frölich, D Krauss, H Spahn-Langguth, H Knauf, E Mutschler. Comparative enantioselective pharmacokinetic studies of celiprolol in healthy volunteers and patients with impaired renal function.
European journal of clinical pharmacology.
1990; 39(6):573-6. doi:
10.1007/bf00316098. [PMID: 1982763] - C Hartmann, D Krauss, H Spahn, E Mutschler. Simultaneous determination of (R)- and (S)-celiprolol in human plasma and urine: high-performance liquid chromatographic assay on a chiral stationary phase with fluorimetric detection.
Journal of chromatography.
1989 Nov; 496(2):387-96. doi:
10.1016/s0378-4347(00)82586-4. [PMID: 2575621] - C R Sirtori, B Johnson, V Vaccarino, G Montanari, M Cremoncini, G Gianfranceschi, M Sirtori, C A Dujovne. Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol.
Clinical pharmacology and therapeutics.
1989 Jun; 45(6):617-26. doi:
10.1038/clpt.1989.82. [PMID: 2567218] - W H Frishman, W Flamenbaum, J Schoenberger, G L Schwartz, D G Vidt, G S Neri, S Greenberg, E Lazar, J C Godfrey, A Stevenson. Celiprolol in systemic hypertension.
The American journal of cardiology.
1989 Apr; 63(12):839-42. doi:
10.1016/0002-9149(89)90053-2. [PMID: 2522723] - S H Taylor. Celiprolol and risk factor reversal in hypertension.
Journal of cardiovascular pharmacology.
1989; 14 Suppl 7(?):S33-9. doi:
10.1097/00005344-198906147-00008. [PMID: 2481788] - J M Herrmann, E O Mayer. A long-term study of the effects of celiprolol on blood pressure and lipid-associated risk factors.
American heart journal.
1988 Nov; 116(5 Pt 2):1416-21. doi:
10.1016/0002-8703(88)90133-0. [PMID: 2903652] - G Mancia. The central and peripheral hemodynamics of celiprolol.
American heart journal.
1988 Nov; 116(5 Pt 2):1405-11. doi:
10.1016/0002-8703(88)90131-7. [PMID: 2903651] - S Kimura, V DeQuattro, P H Hernandez, D D Lee. Effects of celiprolol on plasma renin, aldosterone, norepinephrine and epinephrine in primary hypertension.
The American journal of cardiology.
1988 Oct; 62(10 Pt 1):751-4. doi:
10.1016/0002-9149(88)91216-7. [PMID: 2971310] - H Schneider, M Proegler. Placental transfer of beta-adrenergic antagonists studied in an in vitro perfusion system of human placental tissue.
American journal of obstetrics and gynecology.
1988 Jul; 159(1):42-7. doi:
10.1016/0002-9378(88)90491-7. [PMID: 2899395] - A R Lucarini, N Simonini, L Palmieri, A Salvetti. Long-term humoral and hemodynamic effects of celiprolol.
American journal of hypertension.
1988 Jul; 1(3 Pt 3):211S-213S. doi:
10.1093/ajh/1.3.211s. [PMID: 2970852] - A R Lucarini, A Salvetti. Systemic and renal hemodynamic effects of celiprolol in essential hypertensives.
The American journal of cardiology.
1988 Feb; 61(5):45C-48C. doi:
10.1016/0002-9149(88)90484-5. [PMID: 2963525] - J M Herrmann, F Bischof, F Von Heymann, G Freischuetz, H Burghagen. Effects of celiprolol on serum lipids in systemic hypertension.
The American journal of cardiology.
1988 Feb; 61(5):41C-44C. doi:
10.1016/0002-9149(88)90483-3. [PMID: 2963524] - L H Opie. Qualities of an ideal beta-adrenoceptor antagonist and comparison of existing agents with a new cardioselective hydrophilic vasodilator beta-adrenoceptor antagonist, celiprolol.
The American journal of cardiology.
1988 Feb; 61(5):8C-13C. doi:
10.1016/0002-9149(88)90478-x. [PMID: 2893535] - D Terziivanov, V Vlahov, N Belovezhdov, Z Gerova. Comparison of the antihypertensive effects of celiprolol and acebutolol.
European journal of clinical pharmacology.
1988; 34(2):125-8. doi:
10.1007/bf00614547. [PMID: 2968268] - J M Herrmann, F von Heyman, G Freischütz. Lipid profile improvement following celiprolol.
The Journal of international medical research.
1988; 16 Suppl 1(?):39A-46A. doi:
NULL. [PMID: 2906016] - T P Pruss, K D Lamon, N S Hagen. Celiprolol--overview of 6 years of clinical trials experience.
The Journal of international medical research.
1988; 16 Suppl 1(?):17A-22A. doi:
NULL. [PMID: 2906015] - H Pristautz, F Stradner. [Effect of celiprolol and metoprolol on serum lipids in patients with various forms of hyperlipoproteinemia].
Wiener medizinische Wochenschrift (1946).
1986 Sep; 136(17):443-8. doi:
NULL. [PMID: 2879389] - O E Brodde, R Schemuth, M Brinkmann, X L Wang, A Daul, U Borchard. Beta-adrenoceptor antagonists (non-selective as well as beta 1-selective) with partial agonistic activity decrease beta 2-adrenoceptor density in human lymphocytes. Evidence for a beta 2-agonistic component of the partial agonistic activity.
Naunyn-Schmiedeberg's archives of pharmacology.
1986 Jun; 333(2):130-8. doi:
10.1007/bf00506515. [PMID: 2875397] - N Vlakhov, N Belovezhdov, D Terziivanov, A Koĭchev, G Stefanov. [Plasma levels and the antihypertensive effect of the preparation celiprolol].
Vutreshni bolesti.
1986; 25(6):62-6. doi:
NULL. [PMID: 2951925] - R J Norris, E H Lee, D Muirhead, S W Sanders. A pharmacokinetic evaluation of celiprolol in healthy elderly volunteers.
Journal of cardiovascular pharmacology.
1986; 8 Suppl 4(?):S91-2. doi:
10.1097/00005344-198608004-00018. [PMID: 2427859] - G Brandstetter, H Hoffmann, H Maderbacher, S Eslaminejad. [Uricosuric action of a new beta receptor blocker-diuretic drug combination].
Acta medica Austriaca.
1986; 13(2):29-37. doi:
NULL. [PMID: 2876573]